Monsanto Co. (NYSE:MON)‘s stock had its “buy” rating restated by equities researchers at Deutsche Bank AG in a research note issued on Thursday.
Several other analysts also recently commented on MON. S&P Equity Research reaffirmed a “positive” rating on shares of Monsanto in a research report on Thursday, September 15th. JPMorgan Chase & Co. reaffirmed a “hold” rating on shares of Monsanto in a research report on Thursday, June 30th. Monness Crespi & Hardt reduced their price objective on shares of Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a research report on Monday. Zacks Investment Research downgraded shares of Monsanto from a “hold” rating to a “sell” rating in a research report on Friday, July 1st. Finally, Vetr upgraded Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 target price on the stock in a report on Wednesday, August 3rd. Two analysts have rated the stock with a sell rating, nine have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Monsanto presently has an average rating of “Buy” and a consensus price target of $114.67.
Shares of Monsanto (NYSE:MON) traded up 0.28% during mid-day trading on Thursday, hitting $103.47. 2,178,357 shares of the stock were exchanged. The stock’s 50 day moving average price is $104.90 and its 200-day moving average price is $101.32. Monsanto has a 12-month low of $83.73 and a 12-month high of $114.26. The stock has a market capitalization of $45.28 billion, a P/E ratio of 45.54 and a beta of 1.19.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. The business earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.19) EPS. On average, equities research analysts expect that Monsanto will post $4.46 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.09%. Monsanto’s payout ratio is 89.26%.
In related news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the sale, the chief executive officer now owns 21,583 shares in the company, valued at approximately $2,196,501.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in MON. FMR LLC increased its stake in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the last quarter. Third Point LLC purchased a new stake in Monsanto during the second quarter worth $206,820,000. Carmignac Gestion purchased a new stake in Monsanto during the second quarter worth $197,555,000. TIAA CREF Investment Management LLC increased its stake in Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock worth $481,732,000 after buying an additional 1,560,646 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. increased its stake in Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock worth $176,327,000 after buying an additional 1,147,200 shares during the last quarter. Institutional investors own 79.02% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.